Tue, June 15, 2010
Mon, June 14, 2010
Sat, June 12, 2010
Fri, June 11, 2010
Thu, June 10, 2010
Wed, June 9, 2010
Tue, June 8, 2010
Mon, June 7, 2010
Sun, June 6, 2010
Sat, June 5, 2010
Fri, June 4, 2010
Thu, June 3, 2010
Wed, June 2, 2010
Tue, June 1, 2010
[ Tue, Jun 01st 2010 ]: Market Wire
Covidien???????????????????
Mon, May 31, 2010
Sat, May 29, 2010
Fri, May 28, 2010

Aeterna Zentaris Presents Positive Efficacy and Safety Data for AEZS-108 in Ovarian Cancer at ASCO Meeting


//health-fitness.news-articles.net/content/2010/ .. -aezs-108-in-ovarian-cancer-at-asco-meeting.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


 Conclusion - AEZS-108 was active and well tolerated in patients with heavily pre-treated platinum and taxane resistant ovarian cancer; - The safety profile confirmed the dose of 267 mg/m2; - Hematological toxicity was rapidly reversible; - Non-hematological toxicities were usually limited to lower severity; - Tolerability and CBR compare favourably with topotecan and liposomal doxorubicin; - Overall survival is encouraging as all patients treated with AEZS-108 were platinum-resistant. 

Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear